STRATA SKIN SCIENCES INC (SSKN) Stock News

USA - Nasdaq - NASDAQ:SSKN - US86272A3059 - Common Stock

1.41 USD

+0.02 (+1.44%)

Last: 12/3/2025, 8:00:01 PM

1.39 USD

-0.02 (-1.42%)

After Hours: 12/3/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SSKN Latest News, Press Relases and Analysis

All

Press Releases

20 days ago - By: The Motley Fool

STRATA Skin (SSKN) Earnings Call Transcript

a month ago - By: STRATA Skin Sciences, Inc.

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion

a month ago - By: STRATA Skin Sciences, Inc.

STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update

a month ago - By: Benzinga - Mentions: MSPR MLEC IVA STFS ...

Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket

a month ago - By: Benzinga

STRATA Skin Sciences Rises 25% Pre-Market — Here's Why

a month ago - By: STRATA Skin Sciences, Inc.

STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements

a month ago - By: STRATA Skin Sciences, Inc.

STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek

2 months ago - By: STRATA Skin Sciences, Inc.

Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides

2 months ago - By: STRATA Skin Sciences, Inc.

Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis

2 months ago - By: STRATA Skin Sciences, Inc.

STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis

2 months ago - By: STRATA Skin Sciences, Inc.

New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences’ Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach

3 months ago - By: STRATA Skin Sciences, Inc.

STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering

3 months ago - By: STRATA Skin Sciences, Inc.

STRATA Skin Sciences’ Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements